Iran medical suppliers warn of worsening drug shortages
“The transfer from Taleqan only resolves part of Tehran’s shortage and is not meant to eliminate it altogether,”…
Thalidomide survivors look back at 10 years of a more dignified life
The government announced the support program the following March, and that spring the first cheques arrived: a lump…
Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments
How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…
Switching between weight-loss medications – The Pharmaceutical Journal
After reading this article, you should be able to: Know the mechanism of action of tirzepatide and semaglutide…
A Maze of Clinics: Navigating Ketamine’s Rapid Rise – KQED
A Maze of Clinics: Navigating Ketamine’s Rapid Rise KQEDEvidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy…
Calcutta High Court Injuncts Two Baidyanath Chyawanprash Ads on Dabur’s Plea, Says Edits Cannot Cure Disparagement
The Calcutta High Court has barred Shree Baidyanath Ayurved Bhawan Pvt. Ltd. from using two chyawanprash advertisements after…
The holiday herb that can ease bloating and soothe muscles
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Long Islanders on GLP-1 weight loss drugs navigate the holidays with smaller bites, ‘pregaming’
Linda McMahon, 57, of Patchogue chuckled recalling her Thanksgiving with the “Mounjaro crew” — herself and friends who…
Nasal spray recalled due to possible mold, microbial contamination
Popular nasal decongestants are ineffective, FDA says The leading decongestant used by millions of Americans is ineffective, according…
Eli Lilly’s Weight Loss Superdrug Worked So Well During Trials, Some Quit Over Losing Too Much
There might soon be a new weight loss treatment king on top. This week, Eli Lilly posted the…
Morning Update: Revisiting thalidomide survivors
Good morning. The Globe spoke with thalidomide survivors about how their lives have changed 10 years after a…
High-Dose Wegovy Takes Aim at Lilly’s Zepbound
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) said its high-dose version of Wegovy has received a…